Interestingly, similar to the observations in mouse-derived tissue sample from our experiment, SIRT2 expression level was significantly decreased in NAFLD patients when compared with the healthy group in both datasets (Figure 6C). This evidence concerns the gene SIRT2 and metabolic dysfunction-associated steatotic liver disease.